Exciting News!
We are thrilled to announce that OXOLIFE has reached the final stage of the European Accelerator program! We are both honored and proud to have been selected to present our development program to the EIC Jury in Brussels at the end of January.
Our project aims to revolutionize the fertility field, offering new hope to IVF patients. This milestone is a testament to the dedication of our team and the potential impact our innovation could have on reproductive healthcare.
The European Accelerator program’s support for the development of the first drug designed to enhance embryo implantation will significantly accelerate our time to market, providing thousands of women and couples with the opportunity to achieve their reproductive goals.
To everyone who has supported us on this journey—thank you! We will continue to give our best in convincing the jury of the benefits of this opportunity.